Netherlands Translational Research Center ntrc.nl


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

At the Netherlands Translational Research Center B.V. (NTRC) we develop small molecule drug leads and preclinical candidates for cancer, autoimmune disease and parkinson's disease. We bridge the innovation gap between pharma and universities by connecting our core drug discovery expertises (i.e. assay development, screening, x-ray crystallography and medicinal chemistry) to academic institutes with disease know-how. We scout for the best projects by partnering with world-class academic institute...Show all

At the Netherlands Translational Research Center B.V. (NTRC) we develop small molecule drug leads and preclinical candidates for cancer, autoimmune disease and parkinson's disease. We bridge the innovation gap between pharma and universities by conne...Show all

Company (Alive / Active)

Phone:

Fax:




Netherlands

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Netherlands Translational Research Center $0M Jun 6, 2012

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Netherlands Translational Research Center Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Brabant Development AgencyGovernmentSeed VC
Brabant Life Sciences Seed FundVenture CapitalSeed VC
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
(5,6-dihydro)pyrimido[4,5-e]indolizines Mar 30, 2015 Jan 02, 2018 Patent